The FDA approved the poly ADP ribose polymerase (PARP) inhibitor in June 2023 in combination with enzalutamide for men with ...

The question of life's origin on Earth continues to surprise. A new study challenges an old idea: that a chemical reaction ...

Patients with BRCA-altered uterine leiomyosarcoma treated with PARP inhibitors demonstrated encouraging outcomes.

The bacteria that cause tuberculosis (TB) may have an 'on-off switch' that lets them pause and restart growth, according to a new study. The research helps explain why TB is so hard to treat with ...

Shares of Merus NV (NASDAQ:MRUS) were trading at $54.35, up $12.75, or 30%, on interim data as of Feb. 27 from the phase II trial of bispecific antibody petosemtamab in combination with Merck & Co.

Researchers demonstrated how Mycobacterium tuberculosis modifies its DNA and regulates both replication and gene activity ...

The bacteria that cause tuberculosis (TB) may have an "on-off switch" that lets them pause and restart growth, according to a new study from the University of Surrey and the University of Oxford.

Imunon Inc (NASDAQ:IMNN) stock surged 172% in premarket trading after the company announced significant survival data from its Phase 2 trial of IMNN-001, a treatment for newly diagnosed advanced ...

Imunon Inc. soared by 179% on the heels of phase II Ovation 2 data showing that its IMNN-001 immunotherapy led to a 13-month increase in overall survival among women with ovarian cancer. Patients in ...

A new combination therapy that pairs a radiopharmaceutical (177Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been ...

Former president Joe Biden has been diagnosed with prostate cancer, his office announced on Sunday. The 82-year-old has what ...